Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

SRSF2 mutations in primary myelofibrosis: significant clustering with IDH mutations and independent association with inferior overall and leukemia-free survival

Terra L. Lasho, Thitina Jimma, Christy M. Finke, Mrinal Patnaik, Curtis A. Hanson, Rhett P. Ketterling, Animesh Pardanani, Ayalew Tefferi

Blood (2012) 120 (20): 4168–4171.

https://doi.org/10.1182/blood-2012-05-429696

Published: 2012

Includes: Supplemental data

Journal Articles

Comprehensive Plasma Cytokine Profiling in Polycythemia Vera: Comparison with Myelofibrosis and Clinical Correlates,

Rakhee Vaidya, MD, Nanna Sulai, Shaina A Rozell, MD, Sania S Raza, MD, Sameer Parikh, MD, Thitina Jimma, MD, Christy Finke, BS, Terra L Lasho, MT, (ASCP), Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2011) 118 (21): 3850.

https://doi.org/10.1182/blood.V118.21.3850.3850

Published: 2011

Journal Articles

Prognostic Irrelevance of Vitamin D Insufficiency in Myeloproliferative Neoplasms and De Novo Myelodysplastic Syndromes

Animesh Pardanani, MBBS, PhD, Matthew T. Drake, MD, PhD, Christy Finke, BS, Terra L Lasho, MT, (ASCP), Shaina A Rozell, MD, Thitina Jimma, MD, Ayalew Tefferi, MD

Blood (2011) 118 (21): 5158.

https://doi.org/10.1182/blood.V118.21.5158.5158

Published: 2011

Journal Articles

IDH mutations in Primary Myelofibrosis Predict Leukemic Transformation and Shortened Survival: Clinical Evidence for Leukemogenic Collaboration with JAK2 V617F

Nanna Sulai, Thitina Jimma, MD, Terra L Lasho, MT, (ASCP), Christy Finke, BS, Ryan A Knudson, Rebecca F McClure, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2011) 118 (21): 1751.

https://doi.org/10.1182/blood.V118.21.1751.1751

Published: 2011

Journal Articles

Predictors of greater than 80% 2-year mortality in primary myelofibrosis: a Mayo Clinic study of 884 karyotypically annotated patients

Ayalew Tefferi, Thitina Jimma, Naseema Gangat, Rakhee Vaidya, Kebede H. Begna, Curtis A. Hanson, Daniel L. Van Dyke, Domenica Caramazza, Animesh Pardanani

Blood (2011) 118 (17): 4595–4598.

https://doi.org/10.1182/blood-2011-08-371096

Published: 2011

Includes: Supplemental data

NARROW

SRSF2 mutations in primary myelofibrosis: significant clustering with IDH mutations and independent association with inferior overall and leukemia-free survival

Comprehensive Plasma Cytokine Profiling in Polycythemia Vera: Comparison with Myelofibrosis and Clinical Correlates,

Prognostic Irrelevance of Vitamin D Insufficiency in Myeloproliferative Neoplasms and De Novo Myelodysplastic Syndromes

IDH mutations in Primary Myelofibrosis Predict Leukemic Transformation and Shortened Survival: Clinical Evidence for Leukemogenic Collaboration with JAK2 V617F

Predictors of greater than 80% 2-year mortality in primary myelofibrosis: a Mayo Clinic study of 884 karyotypically annotated patients

Email alerts

ASH Publications

American Society of Hematology

SRSF2 mutations in primary myelofibrosis: significant clustering with IDH mutations and independent association with inferior overall and leukemia-free survival

Comprehensive Plasma Cytokine Profiling in Polycythemia Vera: Comparison with Myelofibrosis and Clinical Correlates,

Prognostic Irrelevance of Vitamin D Insufficiency in Myeloproliferative Neoplasms and De Novo Myelodysplastic Syndromes

IDH mutations in Primary Myelofibrosis Predict Leukemic Transformation and Shortened Survival: Clinical Evidence for Leukemogenic Collaboration with JAK2 V617F

Predictors of greater than 80% 2-year mortality in primary myelofibrosis: a Mayo Clinic study of 884 karyotypically annotated patients

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only